Comparative Chemical Composition of the Essential Oils from Hedyotis Diffusa WILLD and Hedyotis Corymbosa Lam by GC-MS
Journal Title: International Journal of Pharmaceutical Sciences and Developmental Research - Year 2016, Vol 2, Issue 1
Abstract
Introduction: Hedyotis diffusa Willd. (Baihuasheshecao) is an ingredient of herbal commonly consumed in China for cancer treatment and health maintenance. In the market, this ingredient is frequently adulterated by the related species Hedyotis corymbosa Lam.
Authors and Affiliations
Jian Wu, Tairan Yang, Ying Xu, Yi Zhang, Zheng Xiang
In Silico Estimation of Skin Concentration of Dermally Metabolized Chemicals
Background: A great deal of In Silico estimation methods were proposed for skin concentration and permeation of drugs by many researchers including us. The aim of the present study was to expand our In Silico estimation...
Development and Evaluation of Rutin -HPβCD Inclusion Complex Based Mouth Dissolving Tablets
The objective of the present study was to explore inclusion complex of Rutin to improve the aqueous solubility and dissolution rate along with rapid mouth dissolving tablets for oral drug delivery. Rutin is a BCS class I...
Moringa Oleifera: Panaromic View on Nutritional, Therapeutic Activity and Patent Landscape
Phytomedicines are believed to have benefits over conventional drugs and are regaining interest in current pharmaceutical research. Moringa oleifera is a multi-purpose plant used a human food, neutraceutical and alternat...
In-silico analysis of tenidap and its derivative as a novel 5-lipoxygenase inhibitor
Tenidap is a derivative of Flavonoids which are actually plant derivatives, it shows inhibition activity of 5-lipoxygenase. Molecular models were directed to discover molecular docking mode, also to help explain molecula...
Long-term survival after Acute Ischemic Stroke by types of reperfusion therapy, sex and chronic treatments of cardiovascular conditions
Purpose: Compare long-term survival by sex after reperfusion therapies with simultaneous medical therapy of cardiovascular conditions. Methods: AIS patients identified from the population-based register between 01Jan201...